Results 101 to 110 of about 88,811 (347)

Acute pancreatitis after liver transplantation: incidence and contributing factors [PDF]

open access: yes, 1995
In order to assess the incidence and possible predisposing and contributing factors in the development of acute pancreatitis after liver transplantation, we reviewed the medical records of all 1832 adult patients who underwent 2161 orthotopic liver ...
Fung, JJ   +7 more
core   +1 more source

Zosteriform Primary Cutaneous Marginal Zone Lymphoma—A Case Report

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT We report a case of zosteriform PCMZL presenting in a T3–T4 dermatomal distribution not previously described in the literature. Although the varicella zoster virus was not detected in this case, late diagnosis of the acute eruption of zoster or even preceding zoster ‘sine herpete’ cannot be excluded as antigenic triggers.
Natalie Teh   +4 more
wiley   +1 more source

Improved hypercalcemia after debulking of uremic tumoral calcinosis in a parathyroidectomized patient. [PDF]

open access: yes, 2005
Uremic Tumoral Calcinosis (UTC) is a rare complication of chronic kidney disease on dialysis, characterized by large periarticular calcification. Among some cases, hypercalcemia with no conventional etiologies has been reported.
Bornemann, Michael   +2 more
core  

Expert Perspective: Hematologic Malignancies and Vasculitis

open access: yes
Arthritis &Rheumatology, EarlyView.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

Folding, misfolding, and regulation of intracellular traffic of G protein‐coupled receptors involved in the hypothalamic–pituitary–gonadal axis

open access: yesAndrology, EarlyView.
Abstract Background G protein‐coupled receptors are a large and functionally diverse family of membrane receptors involved in a number of biological processes. Like other proteins, G protein‐coupled receptors need to be properly folded in order to traffic to the plasma membrane and interact with agonist.
Alfredo Ulloa‐Aguirre   +5 more
wiley   +1 more source

Hypercalcemia of malignancy and new treatment options

open access: yesTherapeutics and Clinical Risk Management, 2015
Hypercalcemia of malignancy affects up to one in five cancer patients during the course of their disease. It is associated with both liquid malignancies, commonly multiple myeloma, leukemia, and non-Hodgkins lymphoma and solid cancers, particularly ...
Hillel Sternlicht, I. Glezerman
semanticscholar   +1 more source

Hypercalcemia of malignancy treated with cinacalcet

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2017
Hypercalcemia of malignancy is the most common cause of hypercalcemia in hospitalized patients. It is associated with a poor prognosis, since it reflects an advanced cancer stage.
Nikolaos Asonitis   +5 more
semanticscholar   +1 more source

Acute onset neurological deficits and hypocalcaemia associated with nutritional secondary hyperparathyroidism in three juvenile servals (Leptailurus serval)

open access: yesAustralian Veterinary Journal, EarlyView.
Nutritional secondary hyperparathyroidism is a metabolic disorder caused by an imbalance in calcium homeostasis and is typically associated with the feeding of a calcium‐deficient diet. Nutritional secondary hyperparathyroidism has been reported in domestic species, including cats and dogs, as well as captive carnivores and wildlife including lions ...
JL Austen   +5 more
wiley   +1 more source

A novel mutation in the calcium-sensing receptor gene in an Irish pedigree showing familial hypocalciuric hypercalcemia: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Familial hypocalciuric hypercalcemia is a rare autosomal dominant disorder characterized by asymptomatic and non-progressive hypercalcemia due to mutations of the calcium-sensing receptor gene. Disorders of calcium metabolism are very common
Elamin Wael F, de Buyl Olivier
doaj   +1 more source

Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years. [PDF]

open access: yes, 2014
The objective of this study was to assess the safety and efficacy of the fixed combination calcipotriene 0.005% plus betamethasone dipropionate 0.064% topical suspension in adolescents with extensive scalp psoriasis.
Eichenfield, Lawrence F   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy